SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-060128
Filing Date
2024-07-09
Accepted
2024-07-09 16:15:30
Documents
16
Period of Report
2024-07-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0209083-8k_biomx.htm   iXBRL 8-K 64442
2 CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ea0209083ex3-1_biomx.htm EX-3.1 4278
3 AMENDED AND RESTATED CHARDAN HEALTHCARE ACQUISITION CORP. LONG-TERM INCENTIVE PL ea0209083ex10-1_biomx.htm EX-10.1 181219
  Complete submission text file 0001213900-24-060128.txt   514950

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE phge-20240709.xsd EX-101.SCH 3919
5 XBRL DEFINITION FILE phge-20240709_def.xml EX-101.DEF 26852
6 XBRL LABEL FILE phge-20240709_lab.xml EX-101.LAB 37192
7 XBRL PRESENTATION FILE phge-20240709_pre.xml EX-101.PRE 25476
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0209083-8k_biomx_htm.xml XML 6286
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 241107629
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)